Articles by Jim Miller - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Jim Miller

The Macro View

The weak global economy adds to the challenges of bio/pharma companies and their suppliers.
Sep 1, 2012

The weak global economy adds to the challenges of bio/pharma companies and their suppliers.

Channeling Steve Jobs

Service providers must focus on delivering a superior customer experience.
May 1, 2012

Service providers must focus on delivering a superior customer experience.

CMOs Face a Kodak Moment

The evolving bio/pharmaceutical business model poses risk for CMOs.
Mar 1, 2012

The evolving bio/pharmaceutical business model poses risk for CMOs.

Contract Services in 2012

Some recent private-equity buyouts of CROs show both the upside and downside for investors.
Jan 1, 2012

Some recent private-equity buyouts of CROs show both the upside and downside for investors.

Troublesome Signs for Bio/Pharmaceutical R&D

A dearth of late-stage candidates could hurt the pharmaceutical services market in the future.
Dec 1, 2011

A dearth of late-stage candidates could hurt the pharmaceutical services market in the future.

Preparing for the Last War

CROs that have made big acquisitions could be outmaneuvered by evolving sourcing models.
Oct 1, 2011

CROs that have made big acquisitions could be outmaneuvered by evolving sourcing models.

The EU Debt Crisis and CMOs

The EU debt crisis portends of possible negative repercussions for the dose CMO industry.
Sep 1, 2011

The EU debt crisis portends of possible negative repercussions for the dose CMO industry.

Supply Chain Pain

Addressing supply-chain challenges.
May 1, 2011

Addressing supply-chain challenges.

First-Hand Look at India's Pharma Services Sector

Indian manufacturers are not now a threat to Western CMOs, but may be long term.
Mar 1, 2011

Indian manufacturers are not now a threat to Western CMOs, but may be long term.

ADVERTISEMENT

ADVERTISEMENT

Click here